Important Note

The Request for Genomic Analysis order will result in assessment of sample adequacy for genomic analysis, the result of which will post to the patient record. Should a sample be deemed adequate for genomic analysis, the genomic medicine laboratory will reflexively initiate the appropriate solid tumor testing.
 
The Genomic Medicine Laboratory at the University of Vermont Medical Center offers target capture-based next generation sequencing of 30 genes that have clinical utility across solid tumors. Pathologist assessment of sample adequacy and tumor type inform analysis via Gene Panel Solid Tumor or Gene Panel NSCLC. Non-small cell lung cancer is submitted for DNA-based and RNA-based sequencing, the latter for targeted gene fusion analysis in ALK, RET and ROS1.

The test is validated for formalin-fixed paraffin embedded tissue and all non-cell block cytology preparations.  Extracted eluates may be accepted with Pathologist approval.

For outside clients, please use the Genomic Medicine Laboratory Order Form.